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Somatic hypermutation (SHM) is restricted to VDJ regions and their adjacent flanks in 
immunoglobulin (Ig) genes, whereas constant regions are spared. Mutations occur after 
about 100 nucleotides downstream of the promoter and extend to 1–2 kb. We have asked 
why the very 5
 
 
 
 and most of the 3
 
 
 
 region of Ig genes are unmutated. Does the activation-
induced cytosine deaminase (AID) that initiates SHM not gain access to these regions, or 
does AID gain access, but the resulting uracils are repaired error-free because error-prone 
repair does not gain access? The distribution of mutations was compared between uracil 
DNA glycosylase (Ung)-deficient and wild-type mice in endogenous Ig genes and in an Ig 
transgene. If AID gains access to the 5
 
  
 
and 3
 
  
 
regions that are unmutated in wild-type 
mice, one would expect an “AID footprint,” namely transition mutations from C and G in 
Ung-deficient mice in the regions normally devoid of SHM. We find that the distribution of 
total mutations and transitions from C and G is indistinguishable in wild-type and Ung-
deficient mice. Thus, AID does not gain access to the 5
 
 
 
 and constant regions of Ig genes. 
The implications for the role of transcription and Ung in SHM are discussed.
 
Somatic hypermutation (SHM) of Ig genes
requires the function of activation-induced
cytosine deaminase (AID; references 1 and 2).
Although unidentified, AID may have an RNA
substrate (3). However, in vitro, AID deaminates
monomeric dCTP (4), single-stranded DNA (5–
7), transcribed double-stranded DNA (8–11),
and supercoiled double-stranded DNA (12).
Moreover, studies in cells deficient in uracil
DNA glycosylase (Ung) activity strongly support
the idea that AID deaminates cytosines in
DNA directly to produce U:G DNA mispairs
(13–15). In the absence of Ung, C mutations
are almost exclusively C to T (and for C
deamination on the opposite strand, comple-
mentary G to A) transitions, as expected if
deoxyuridines resulting from AID cytidine
deamination are left unrepaired before replica-
tion. Indeed, in activated B cells, uracil excision
appears to be accomplished mostly by Ung,
with minimal contribution from the SMUG1
uracil glycosylase (16, 17). Although transition
mutations in Ung–wild-type mammals are the
most common SHMs from C and G, transver-
sions are also frequent and are thought to arise
either entirely (13, 15) or in part (18) from
Ung-mediated base excision repair. Ung-
mediated excision of the uracil base creates an
abasic site that, if used as a template for DNA
synthesis, could lead to any mutation from C
or G (for review see reference 19). Alterna-
tively, processing of the abasic site to generate
a single-stranded gap might lead to mutations
when followed by error-prone DNA synthesis
involving lesion-bypass polymerases (pols), of
which pol 
 
 
 
, pol 
 
 
 
, and pol 
 
 
 
 have been impli-
cated in SHM (18). Finally, the U:G mispair
could also be processed by the mismatch repair
system. The SHM pattern in mismatch repair
(Msh)2- and pol 
 
 
 
–deficient B cells supports a
model in which Msh2/6-mediated removal of
the U:G mismatch, followed by pol 
 
 
 
 and pol
 
 
 
 error-prone DNA synthesis, leads mainly to
mutations from A and T (20, 21).
The mechanism by which SHM is targeted
almost exclusively to Ig DNA is a mystery.
Although Ig V regions accumulate mutations at
an average frequency of 10
 
 
 
4
 
–10
 
 
 
3
 
 mutations/
base pair/cell generation (
 
 
 
10
 
6
 
-fold higher
than the frequency of spontaneous mutations),
with a few exceptions (22–25), most other
genes are not mutated. Transcription of the
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target DNA is required for normal SHM because (a) remov-
ing an enhancer from a murine Ig transgene decreases the
SHM frequency (26); (b) mutation frequency correlates posi-
tively with the level of transcription regulated by an inducible
promoter upstream of a transgene in a mutating B cell line
(27); (c) the frequency of mutations is dependent on distance
from the promoter (28–33); and (d) duplicating an Ig
 
  
 
pro-
moter upstream of the normally unmutated Ig C region in an
Ig
 
 
 
 transgene results in initiation of mutations in the C re-
gion with a similar dependence on distance from the pro-
moter (34). The latter observation led to the proposal that a
“mutator factor,” perhaps an endonuclease, is recruited to
transcription complexes initiating at Ig loci, travels with the
complex, and gets deposited stochastically where it nicks the
DNA, perhaps when the RNA pol pauses (34, 35). Error-
prone repair of nicks would generate mutations. Due to a
high chance of deposition within the first 1–2 kb from the
promoter, the mutator factor was proposed to be absent from
transcription complexes beyond 1–2 kb downstream of the
transcription start, thereby protecting the C region from mu-
tation (34, 35).
We sought to determine whether AID is a transcription-
coupled mutator factor in vivo. In vitro, deamination of dou-
ble-stranded linear DNA by AID requires transcription (8–11)
or a putative negatively supercoiled conformation (12). Nega-
tive supercoils are generated behind an elongating transcrip-
tion complex (36). However, that transcription alone creates
the appropriate substrate for AID does not explain how DNA
within the first 
 
 
 
200 bp and beyond 1–2 bp of the transcrip-
tion start (i.e., Ig C regions), and most other genes that are
highly transcribed in germinal center B cells, remain essen-
tially mutation-free. To address this question, we considered
two possibilities: transcription complexes at or near the tran-
scription initiation site load and carry AID, which deaminates
cytosines for 1–2 kb before becoming inactive or dissociating
from the elongating transcription complex, or AID deami-
nates cytosines made accessible by transcription or supercoiled
conformation throughout Ig genes and in other loci.  How-
ever, although repair of U:G mismatches would be error-free
in the very 5
 
 
 
 and C regions of Ig loci, and in other loci (like
during Ung-mediated repair of replication errors; references
37 and 38), error-prone repair could occur in V regions be-
cause error-prone repair factors (or factors that recruit them)
are targeted preferentially to Ig V regions.
Whether targeting of AID or of error-prone repair causes
the skewed distribution of SHM was addressed by comparing
the distribution of mutations relative to the transcription start
site in vivo, in murine B cells wild-type (Ung
 
 
 
) or deficient
(Ung
 
 
 
) for Ung. Importantly, these experiments were per-
formed under conditions of endogenous rather than overex-
pressed levels of AID and therefore should be most appropri-
ate for detecting Ig-specific targeting of SHM. SHMs in
endogenous Ig loci and in an unselected transgene (39) were
analyzed. We reasoned that C to T (and complementary G to
A) transition mutations in the absence of Ung represent AID-
catalyzed cytosine deaminations, i.e., an AID “footprint,”
based on the following considerations. In the absence of
Ung, uracils created by AID result in transitions from C and
G when the DNA is replicated. It is unlikely that many tran-
sitions from C or G occur by the interaction of error-prone
pols with mismatch repair. The major error-prone pols found
to be involved in SHM are pol 
 
 
 
 and pol 
 
 
 
 (18, 20, 21, 40).
Both have the highest error rates when copying T, leading to
transitions from A (T) (41, 42). In the Ung
 
 
 
 mice, where
MMR would still be active, there is no increase in mutations
from A or T (15 and see Figs. 1–4). Thus, the transitions
from C and G are likely an AID footprint (see Discussion).
We have mapped mutations relative to each transcription ini-
tiation site. Strikingly, the AID footprint is virtually absent in
the first 100 transcribed nt, low between 100–200 nt, and
significantly reduced beyond 
 
 
 
1.5 kb of the transcription
start, supporting the idea that AID activity is coupled to the
transition between transcription initiation and elongation
from Ig promoters.
 
RESULTS
 
To determine whether AID deamination, or post-AID pro-
cessing of the deaminated cytosine, determines the mutation
distribution within Ig genes, we mapped C to T (and G to
A) mutations in two endogenous Ig loci, the 
 
 
 
1 light chain
locus and VJ558-rearranged IgH genes, as well as in an Ig
 
 
 
transgene in germinal center B cells of immunized Ung
 
 
 
 and
Ung
 
 
 
 control mice.
 
AID deaminations are essentially absent from regions upstream 
and within 
 
 
 
100 bp downstream of the transcription start site 
in endogenous rearranged V
 
 
 
1 genes
 
Upstream and immediately downstream of the transcription
start site, SHMs have been reported to occur at very low fre-
quencies, if at all (28–31). To determine whether this 5
 
 
 
 re-
gion is protected or not from AID-mediated cytosine deam-
ination, we mapped mutations in rearranged 
 
 
 
1 light chain
genes. In mice, there are only three V
 
 
 
 genes (43), and
 
 
 
60% of 
 
 
 
-expressing B cells derive from V
 
 
 
1/J
 
 
 
1 rear-
rangements (44). Genomic DNA from PNA
 
high
 
 germinal
center B cells of immunized Ung
 
 
 
 or Ung
 
 
 
 mice was used
as a template to PCR amplify rearranged 
 
 
 
1 genes. As re-
ported previously for SHM in other Ig loci of Ung
 
 
 
 cells
(15), mutations from C and G are almost exclusively transi-
tions in the Ung
 
 
 
 as compared with Ung
 
 
 
 mice (Fig. 1 A).
The specific mutation pattern shift favoring C to T (and G
to A) mutations in Ung
 
 
 
 mice in all loci assayed here (see
below) further substantiates that C and G transitions likely
represent an AID footprint.
A 991-bp region of V
 
 
 
1 between 453 bp upstream and
538 bp downstream (ending at the 3
 
 
 
 region of J
 
 
 
1) of the
start of transcription of 
 
 
 
1 was analyzed for SHM (Fig. 1 C).
Both the subset of transition mutations from C and G as well
as the total mutations are plotted with respect to their posi-
tion in Fig. 1 B (note that all mutations from A, C, G, and T 
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are plotted below the zero ordinate, whereas only the transi-
tions from C and G are plotted above the zero ordinate).
Similar to previous reports, we found only three mutations
between 
 
 
 
453 and 
 
 
 
100 bp relative to the transcription
start in wild-type mice. Mutations in Ung
 
 
 
 mice, including
C and G transition mutations, were almost entirely absent
from 
 
 
 
453 to 
 
 
 
242 bp. In both Ung
 
 
 
 and Ung
 
 
 
 mice, mu-
tations eventually reached a plateau (at about 
 
 
 
200 or 
 
 
 
350
bp, respectively). Elevated numbers of mutations at comple-
mentarity-determining region (CDR)1, CDR2, and CDR3
(Fig. 1 B) suggest that B cells expressing a functional V
 
 
 
1-
J
 
 
 
1 gene were selected in germinal centers for their affinity
to the immunogen.
The paucity of mutations upstream of the plateau is not
due to a lack of AID hotspots in the upstream and very 5
 
 
 
 re-
gions (Table I). Therefore, because C or G transition muta-
tions in Ung
 
 
 
 mice, i.e., AID footprints, are virtually absent
upstream and within the first 100 bp of the transcription start,
AID appears not to gain efficient access to this 5
 
 
 
 region of 
 
 
 
1.
Figure 1. Mutations in the very 5  end of the  1 gene in Ung  and 
Ung  mice. In the Ung  background, a total of 29 clones were analyzed, 
of which 23 clones contained one or more mutations in a 991-bp region 
between  453 upstream and  538 bp downstream of the start of transcrip-
tion in the rearranged VJ 1 gene. There were a total of 104 mutations, 
including 38 transitions from C and G, among these 23 clones. In the 
Ung  background, 30 clones were analyzed, of which 18 clones contained 
one or more mutations for a total of 43 mutations, including 26 C and G 
transitions. (A) Summary of mutation patterns expressed as a percentage 
of total mutations. In the adjusted column, variability of A:C:G:T contents 
in 991 nt of the analyzed region was normalized for base content. A,27.1%; 
C, 22.6%; G, 19.3%; T, 31.0%. (B) Distribution of mutations from  450 to 
 538 relative to the start of transcription ( 1). Mutations equal the 
number of mutations at each position per the total number of mutated 
clones sequenced times 100. (C) The three CDRs are indicated in the 
diagram of the V 1 gene below the graph.
Figure 2. Mutations in the very 5  end of the RS transgene. 69 clones 
were analyzed in the Ung  background, and 31 clones contained one or more 
mutations between positions  301 to  964 for a total of 320 mutations, 
including 70 transitions from C and G. In the Ung  background, 138 clones 
were analyzed and 40 clones contained more than one mutation for a total 
of 244 mutations, including 118 transitions from C and G. (A) Summary of 
mutation patterns in the 1,265 nt of the analyzed region, expressed as a 
percentage of total mutations. In the adjusted column, variability of 
A:C:G:T contents in 1,265 nt of the analyzed region was normalized for 
base content. A, 28.6%; C, 20.7%; G, 21.2%; T, 29.5%. (B) Distribution of 
mutations from  300 to  964 relative to the start of transcription ( 1). 
Mutations equal the number of mutations at each position per total 
number of mutated clones sequenced times 100. (C) Map of RS transgene 
designed to test certain parameters of SHM targeting (reference 39). EPS 
and RS are 96 nt insertions in the V and J regions, respectively. 
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Mutations in the 5
 
 
 
 region of the RS transgene
 
B cells require surface Ig expression for survival (for review
see reference 45), and mutations in Ig genes are selected for
their ability to confer increased antigen affinity. Because mu-
tations in the promoter, leader, or leader-V intron region of
the endogenous 
 
 
 
1 gene may have been selected against and
might therefore be undetected, we also examined the 5
 
 
 
 re-
gion of an unselected murine Ig transgene. The RS trans-
gene is based on a rearranged Ig
 
 
 
167
 
 gene, including its na-
tive promoter and both intronic and 3
 
 
 
 enhancer elements,
and was reported previously to acquire 5–10-fold more
SHMs than similar transgenes due to two E boxes (5
 
 
 
 CAG-
GTG 3
 
 
 
), DNA binding elements located 
 
 
 
900 bp from the
promoter (in the RS region; Fig. 2 C) to which E2A pro-
teins can bind (46). Despite increasing the mutation fre-
quency of all regions of the RS transgene, the E boxes do
not increase the level of RS transgene transcription (46).
The RS transgenic mice were bred onto Ung  and
Ung  backgrounds and immunized to collect activated B
cells from germinal centers. SHMs were mapped in a 5  re-
gion of the RS transgene between nt positions –301 and
 964 relative to the transcription start (Fig. 2 C). As in the
endogenous  1 gene, Ung deficiency caused a shift in the C
and G mutation pattern predominantly to transitions (Fig. 2
A). Therefore, the molecular mechanisms governing muta-
tion patterns appear to be similar between endogenous Ig
genes and the RS transgene. In the Ung  background, there
were no mutations upstream of the promoter and in the first
83 bp of the transcribed region (Fig. 2 B). The numbers of
mutations per 100 bp become comparable between  200
and  964 bp, such that the mutation frequency reaches an
apparent plateau after  200 bp, similar to  1. In Ung 
mice, there was one mutation upstream of the promoter and
no mutations within the first 101 bp from the transcription
start. Three mutations were seen in the next 50 bp, and an
apparent plateau of mutations was reached around  180
(Fig. 2 B). Thus, the very 5  end of the RS transgene lacks
mutations in both Ung  and Ung  situations.
In Ung  mice, one of the 138 clones analyzed contained
eight mutations upstream of the transcription start of the RS
Table I. Statistics of mutation frequencies and hotspots in VJ 1
 
From (bp) To (bp) Ung  p-value Ung  p-value Hotspots
(no. of mutations) (no. of mutations)
 400  3 0 1 0— 1— 8
 300  201 0 — 0 — 11
 200  101 0 — 1 — 13
 100  11 — 0 — 1 2
1 100 2 0 1 0.001 12
101 200 12 0.035 0 0.0004 16
201 300 24 0.89 6 0.27 15
301 400 21 0.72 14 0.99 11
401 500 41 0.99 18 0.99 12
Table II. Statistics of mutation frequencies and hotspots in RS transgene
RS transgene
From (bp) To (bp) Ung  p-value Ung  p-value Hotspots
(no. of mutations) (no. of mutations)
 300  201 0 — 1 — 11
 200  101 0 — 0 — 10
 100  10 — 0 — 1 5
1 100 2  00  01 1
101 200 16 0.0005 14 0.0036 12
201 300 32 0.46 25 0.53 12
301 400 39 0.87 48 0.99 7
401 500 31 0.39 44 0.99 7
501 600 33 0.53 23 0.36 8
601 700 42 0.95 19 0.11 11
701 800 41 0.93 16 0.029 10
801 900 53 0.99 31 0.89 12JEM VOL. 202, November 21, 2005 1447
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transgene. The mutations were all from A or T, and mostly
from A to T, and therefore did not represent the AID foot-
print directly. The RS transgenic mouse has two copies of the
RS transgene in tandem. We discovered previously that the
3    enhancer contains a promoter that can drive SHM (47).
Thus, the 5  mutations in this rare clone may have gained
mutations from the 3  promoter of the upstream transgene,
and this clone was not included in the analysis of Ung  mice.
To rule out the possibility that lack of AID hotspots re-
sults in the mutation pattern observed in the 5  region of the
RS transgene, the distribution of WRC and GYW motifs
(7) was analyzed (Table II). On average, there are 11.3
hotspots per 100 bp in the 5  end of the RS gene. The up-
stream regions are not impoverished for hotspots, and the
consistency of hotspots throughout the gene to  964 bp
does not correlate with the absence of mutations in the 5 
end of the transcribed region.
Because the number of mutations in the first 200 bp is
very low, the frequency of mutations in the 5  portion of the
RS transgene was analyzed statistically. To test whether a
very low number of mutations in the first 200 bp can result
from random mutation, we defined our null hypothesis to be
that mutations occur at a flat rate between  1 and  964 bp
of the transcription start. For the Ung  mice, in 10,000 simu-
lations of randomly placing a total of 318 mutations between
bp  1 and  964, observing only two mutations or fewer
within the first 100 bp is unlikely (P   0; Table II). For
 101 to  200 bp, observing only 16 mutations or fewer is
also very unlikely in this region if mutations occur randomly
because there were only 5 out of 10,000 cases with 16 or
Figure 3. Mutations in the mutation plateau and 3  thereof in the 
endogenous IgH chain gene. In Ung  mice, 21 of 41 total J2-rearranged 
clones and 43 of 100 total J4-rearranged clones had one or more mutations. 
In Ung  mice, 28 of 53 total J2-rearranged clones and 34 of 64 total J4-
rearranged clones had one or more mutations. (A) Summary of mutations 
downstream of J4 (between nt 1,284 and 2,428) in J4-rearranged genes 
pooled from three mice of each genotype. Numbers represent percents of 
the total mutations. In the adjusted column, variability of A:C:G:T contents 
of the analyzed region was normalized for base content. A, 29.1%; C, 16.2%; 
G, 24.2%; T, 30.5%. (B) Distribution of mutations 3  of JH2 (between nt 334 
to 2,428, top) and 3  of JH4 (between nt 1,284 and 2,428, bottom) in Ung  
(left) and Ung  mice (right), respectively. All nt numbering is according to 
GenBank accession number X53774. Mutations equal the number of 
mutations at each position per total number of mutated clones sequenced 
times 100. For each graph, the number of total mutations and transitions 
plotted from C and G is indicated in the bottom or top-right corner. 
(C) Diagram of VDJ2 and VDJ4 rearrangements. The shaded area shows the 
staggered decline of mutations in these two rearrangements.NO AID ACCESS TO THE 5  AND 3  ENDS OF IG GENES | Longerich et al. 1448
fewer mutations in the simulations (P   0.0005). For the
Ung  mice, the same null hypothesis was tested by placing
260 mutations randomly between nt  1 to  964 in the RS
transgene. Again, observing no mutations between  1 and
 100 (P   0) and 14 mutations between  101 and  200 bp
(P   0.0036) was very unlikely, indicating that mutations are
very unlikely to be distributed randomly in this region. The
same conclusions are obtained when applying similar statisti-
cal analysis to the mutations in the endogenous  1 gene, de-
spite smaller numbers of mutations (Table I).
The rejection of the null hypothesis for the first 200 bp
of both Ung  and Ung  backgrounds indicates that the mu-
tation processes occurring within the first 200 bp are statisti-
cally different from the processes at  201 to  964. The re-
sults suggest that SHM does not operate in the first 100 bp
and operates at a reduced level from   100 to   200 bp.
Moreover, AID appears not to have access to the 5 end of Ig
genes (see Discussion).
The frequency of AID deaminations decreases with 
increasing distance downstream of transcription 
initiation in endogenous IgH chain genes
To analyze the decline in mutation frequency in 3  regions
beyond 1–2 kb from the transcription start, mutations were
mapped in the intron between JH4 and C  in VHJ558-rear-
ranged IgH genes. IgH chain genes rearrange using one of
four possible JH segments, such that the intronic DNA imme-
diately downstream of J4 is closer to the start of transcription
in D-J4 rearrangements compared with D-J rearrangements
with upstream JH segments, J1, J2, or J3, due to deletion of
the DNA between the recombined D and J segments. This
feature allows comparison of the frequency of SHM in an
identical, endogenous segment of DNA when located at dif-
ferent distances from the start of transcription (Fig. 3 C). Mu-
tation frequencies between J3 and J4 rearrangements report-
edly differ 3.6-fold (4.0   10 3 vs. 14.4   10 3, respectively)
in a 314-bp segment encompassing two thirds of the 3  end
of J4 and the immediate 3  intronic flank (33).
We performed a similar analysis of mutations in the J4-
flanking intron segment in immunized Ung  and Ung  mice
to determine whether AID gains equal access to this region
regardless of the distance between this DNA segment and the
start of transcription. (We did not consider switch region mu-
tations that would be located further 3  and are probably in-
duced independently of VDJ region mutations.) The distri-
bution of mutations in J2- and J4-rearranged genes is shown
in Fig. 3 B, top and bottom, respectively. For both J2- and
J4-rearranged genes, the sequence was analyzed between the
3  end of the rearranged J segment and the 3  primer used for
PCR amplification (located 1,108 bp downstream of J4; Fig.
3 B). Data in Fig. 3 represent mutations pooled from three
mice, either Ung  or Ung , and as reported previously for
this locus (15), mutations from C or G in Ung  mice are pre-
dominantly transitions (Fig. 3 A). Moreover, the distribution
of mutations in the J4-C  intron region is similar between
Ung  and Ung  mice. In both Ung  and Ung  mice, all
mutations are more frequent within and near the rearranged J
segment than further downstream (Fig. 3 B). Finally, in the
segment 3  of J4 present in both J2 and J4 rearrangements,
but located  950 bp further from the transcription start in
J2-rearranged genes, mutations are  12- and 5-fold higher in
J4-rearranged genes versus J2-rearranged genes in Ung  and
Ung  mice, respectively (Fig. 3 B). The subset of C and G
transition mutations differs  33- and 6-fold in Ung  and
Ung  mice, respectively, for the same region. Thus, inde-
pendent of DNA sequence, high levels of cytosine deamina-
tion by AID occur only up to  600-700 bp downstream of
the 3  end of the rearranged JH gene. Further 3 , mutations
and transitions from C and G also decrease drastically in the
absence of Ung.
There appear to be more mutations in the 3  region (be-
yond  1284) in the Ung  mice as compared with the Ung 
mice. We speculate that this might be due to the technical
difficulty of PCR amplifying long regions of contiguous ge-
nomic Ig DNA, which produces a significant fraction of hy-
brid PCR products as observed previously for the IgH locus
using the same PCR primers (33). We excluded all detectable
hybrid products from this analysis using polymorphisms in the
analyzed region (see Materials and methods), but of course
hybrids between DNA molecules derived from the same allele
would not be detectable. As a consequence, some of the mu-
tations downstream of J2 might be derived from hybrids (for
example, derived from a J3- or J4-rearranged segment with
mutations after  1284), possibly leading to an overestimate of
the mutations 3  of J4 in clones scored as J2-rearranged. Con-
versely, hybrid PCR artifacts would lead to an underestima-
tion of the mutations after  1,284 in J4-rearranged clones via
similar events. As a consequence, we expect that the observed
difference in mutation frequency between Ung  and Ung 
mice beyond  1,284 is not significant.
Mutations in the mutation plateau and 3  regions of 
the RS transgene
Just as for the   light chain analysis, mutations in the heavy
chain J-C intron may have been selected against because of
unknown functional consequences (e.g., RNA splicing,
IgH intron enhancer function, etc.) and thus would be un-
detected. Therefore, we also examined the 3  distribution
of mutations in the unselected RS transgene. To examine
whether there is a decline in mutation frequency with in-
creasing distance from the start of transcription as is seen in
endogenous IgH genes, two sections in the RS transgene
were analyzed (Fig. 4, B and C). As in the endogenous IgH
locus (Fig. 3 B), mutations are frequent between  162 and
 1,078 and 10–13-fold less frequent 500 bp further down-
stream between  1,580 and  2,900. A similar decline in
mutation frequency was observed in the subset of transition
mutations from C and G, both in the presence and absence
of Ung (e.g., a sevenfold decrease in Ung ). The paucity of
mutations in the 3  region beyond 1.5 kb of the RS trans-JEM VOL. 202, November 21, 2005 1449
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gene is particularly striking when considering the large mu-
tation load of some clones (e.g., in Ung  mice, the maxi-
mum number of mutations per clone in the region between
 162 and  1,078 was 55, whereas a maximum of only 9
mutations per clone was found between  1,580 and
 2,900), suggesting that not only the 5  but also the 3 
boundary of mutations is rather defined in the RS trans-
gene. Moreover, DNA elements sufficient to define both
the transcriptional correlation of SHM, as well as the muta-
tion pattern, must be contained within the elements present
in the RS transgene.
The WRC trinucleotide in which the C (or G in the
complementary GYW sequence) that is mutated is a hotspot
for AID targeting in vitro (7). To determine whether this is
also true in vivo, we compared C and G mutations in
hotspots and nonhotspots in Ung  versus Ung  mice in the
RS transgene between  162 and  1078 bp. Interestingly,
59 and 64% of mutations from C and G were found in
hotspots in Ung  and Ung  mice, respectively, suggesting
that the WRC/GYW hotspots are also preferred AID sub-
strates in vivo, and that targeting of these hotspots is deter-
mined by AID rather than post-AID repair steps.
DISCUSSION
Relationship of SHM to transcription
Evidence for a correlation between SHM and transcription is
abundant (for review see references 48 and 49). Yet, how
SHM and transcription are related mechanistically is un-
known. Recent in vitro studies of the function of AID sug-
gest that transcription creates a substrate for AID, perhaps sin-
gle-stranded DNA (for review see reference 49) or negatively
supercoiled double-stranded DNA (12). However, in B cells
undergoing SHM, how mutations are restricted mostly to V
regions of Ig DNA in vivo, where Ig C-region DNA and
many other genes are transcribed, is not understood.
C to T (and the corresponding G to A) transition muta-
tions in the absence of Ung likely represent AID-catalyzed
mutations (also see below). If AID initiates the SHM pro-
cess, and AID (rather than error-prone repair) is directed to
the target by transcription, then the frequency of AID-pro-
moted transition mutations from C and G in Ung  mice
should follow the distribution frequency of typical SHM in
an Ung  mouse. Precisely this pattern was observed both in
endogenous Ig loci and in the RS transgene in vivo, where
C and G transition mutations overlapped with the distribu-
tion of all mutations in both Ung  and Ung  mice. More-
over, the fact that the promoter and general region upstream
of the transcription start are essentially devoid of C or G
transition mutations in Ung  mice suggests that targeting of
AID requires transcribed DNA.
Transcription coupling of AID activity might be accom-
plished by association of AID with the transcription complex
during transcription elongation. (AID–RNA pol complexes
have been observed so far only in experiments in which AID
was epitope-tagged and overexpressed [50]). Whether physi-
ological levels of AID bind RNA pol has not been demon-
strated. Alternatively, transcribed V-region DNA might be
in a special conformation that allows access to AID that is
not associated with RNA pol. AID might be tethered to Ig-
specific enhancers (or to cis elements specific to other genes
that undergo SHM) and may thus be available in the vicinity
of target DNA.
Within transcribed DNA, the first  100 transcribed bp
are essentially mutation-free, indicating that these bp are not
deaminated by AID. There are several possible reasons for
the lack of access by AID to the very 5  end. First, although
Figure 4. Mutations in the mutation plateau and 3  thereof in the 
RS transgene. Two regions of the RS transgene were PCR amplified to 
map mutations between  162 to  1,078 and  1,580 to  2,900 bp 
downstream of the transcription start (at position  1). (A) Summary of 
mutation patterns in the region between nt 162 and 1,078 in Ung  and 
Ung  mice. Numbers represent percents of the total mutations. In the 
adjusted column, variability of A:C:G:T contents of the analyzed region 
was normalized for base content. A, 28.14%; C, 20.07%; G, 23.01%; T, 28.79%. 
(B) Distribution of mutations in two regions of the RS transgene down-
stream of transcription. Mutations equal the number of mutations at each 
position per total number of clones sequenced times 100. The total number 
of mutations and transitions from C and G in each region is indicated in 
parentheses at the bottom or top of each plot. (C) Map of RS transgene 
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AID may interact with the transcription complex (34), it
may do so only when RNA pol II is in the processive mode.
In this case, AID may not be loaded at the promoter, but
rather after the pol has switched from the abortive to the
processive mode (51, 52). These two modes are distin-
guished by the phosphorylation state of the pol. In the abor-
tive phase, the COOH-terminal domain of the largest sub-
unit of RNA pol II is phosphorylated at serine-5 of the
heptad repeats. Gradually, these heptad repeats acquire a dif-
ferent phosphorylation pattern, such that in the processive
phase, serine-5 phosphorylation has been removed and
serine-2 is phosphorylated. Although the switch to the pro-
cessive mode likely begins before  100 bp from the tran-
scription start, an AID-compatible phosphorylation state
may not be present until after  100 bp. AID would be ex-
pected to access DNA that is associated with RNA pol, or,
more likely, in negative supercoils arising behind the pol (see
below). This scenario implies that AID travels with the elon-
gating transcription complex.
Second, the lack of mutations in the upstream region
might be due to a lack of negative supercoils in that region.
Based on the possibility that AID gains access to DNA in
negatively supercoiled regions accumulating behind the
RNA pol (12), transcription-associated negative supercoils
may need to reach a certain threshold level before AID can
interact with the DNA. It is conceivable that negative super-
coil propagation in the upstream direction is restricted to the
transcribed portion of the gene due to occupancy of the pro-
moter by multiple factors that anchor the gene in a particular
position in the nucleus. This scenario could apply whether
or not AID was associated with the transcription complex.
Finally, an “inhibitory” nucleosome might be positioned
somewhere over the first  146 bp downstream of the pro-
moter. Promoters are often flanked by positioned nucleo-
somes due to the occupancy of the promoter itself by tran-
scription factors that may exclude nucleosomes (53). In this
case, AID would begin to gain access to the DNA after the
dyad center of the nucleosome (at   73 bp). Finding this
result would mean that transcription can ignore such a nu-
cleosome but AID cannot.
In contrast to the 5  end, the clear decrease of mutations
beyond  1 kb, in Ung  mice to the same degree as in Ung 
mice, is explained most easily by the hypothesis that AID is
associated with the elongating transcription complex. AID
may act stochastically on the DNA during elongation and, as
a result of interacting with DNA, be unable to remain
bound to the transcription complex. Alternatively, AID may
need to be deposited on the DNA by a conformational
change of the transcription complex, e.g., when the RNA
pol pauses. If AID cannot reload after deposition, again, mu-
tations would stochastically decrease in frequency toward the
3  end of the gene.
Alternative hypotheses for the lack of mutations in the 3 
ends of Ig genes are as follows. First, AID might instead be
tethered in the vicinity of the Ig genes, for example, at spe-
cific enhancers from where it prefers to target transcribed
DNA without associating with the transcription complex.
However, if so, why would AID mutations rise and fall in a
relatively constant pattern from the 5  to the 3  region of the
gene? When the intronic Ig  enhancer was moved to a posi-
tion 3  of the C region and an Ig promoter placed upstream
of the C region, the V region was still mutated in the normal
pattern (34). Second, chromatin differences between the V-
and C-region DNA in heavy chain genes have been ob-
served (54). However, in murine light chain genes, both the
V and C regions were found to be in an active chromatin
conformation in vivo (55). Thus, chromatin differences be-
tween V- and C-region DNA may not explain restriction of
mutations to V-region DNA. Finally, it is possible that dur-
ing SHM, certain rounds of transcription of the Ig genes
abort somewhere in the middle of the gene. Clearly, full-
length mRNAs are produced in PNAhigh B cells and mutat-
ing B cell lines, but short transcripts may also be made, al-
though they would be predicted to be unstable. (We have
been unable to find evidence for short transcripts; unpub-
lished data). For AID to associate only with abortive tran-
scription complexes, the rounds of transcription resulting in
short transcripts would have to be differentiable from rounds
resulting in full-length transcripts. Thus, the original hy-
pothesis (34, 56) that a mutator factor, i.e., AID, travels with
the RNA pol during Ig gene transcription seems more
likely. That is, if all bases in a length of DNA are equal tar-
gets for AID, but AID always begins acting from the same
point (just downstream of the transcription start) and travels
in only one direction, cytosines at the start of AID’s path
have a greater chance to become deaminated than those fur-
ther downstream if AID is deposited at its site of action.
Ung and mismatch repair in SHM
A predominance of transition mutations from C and G is not
only a hallmark of SHM in Ung  mice, but also of mice lack-
ing proteins of the mismatch repair system (16, 57–59). In ad-
dition, mutations at A and T bases are reduced in Msh2- and
Msh6-deficient mice, leading to the proposal that both Ung
and Msh2 can recognize the U:G mismatch generated by
AID, although the SHM pattern would be different depend-
ing on the DNA repair enzymes involved. That is, Ung-
mediated uracil removal and subsequent replication over the
abasic site, or nicking and removal of the abasic site followed
by error-prone DNA synthesis, were proposed to generate
mutations from C or G almost exclusively. In contrast,
Msh2-mediated removal of a single-stranded DNA patch that
extends beyond the original U:G mispair could lead to muta-
tions from any base, including A or T bases, during resynthe-
sis of the removed strand. In this scenario, Msh2-mediated
SHM would necessarily require error-prone synthesis. pol  
has been implicated in this role, especially because (a) the pat-
tern of synthesis errors made in vitro by Pol   (60), which
appears to be stimulated by Msh2 (61), resembles the SHM
pattern from A and T, and (b) SHMs from A and T are re-JEM VOL. 202, November 21, 2005 1451
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duced in Pol  –deficient humans and mice (21, 61). How-
ever, if considering Msh2 and Ung as independent paths to
generate SHMs from a common U:G mismatch, the SHM
patterns in mice lacking one of the repair systems are difficult
to explain. For example, why are mutations from A or T in
Ung  mice unaffected? One would expect them to be in-
creased if, in the absence of Ung, the Msh2–Pol  /Pol  
pathway predominates. Importantly, mismatch repair appears
not to be limiting in germinal center B cells (62). Also, why
are transitions from C and G increased in Msh2-deficient
mice (57–59)? In the absence of Msh2 in this model, Ung
would have been expected to gain more access, thereby still
generating transversion mutations from C and G.
To explain this conundrum, we propose that Msh2 and
Ung are factors in codependent systems in SHM. Msh2-
mediated mismatch “repair” is expected not to be strand-
specific for the U-containing strand, presumed here to be
either the transcribed or the nontranscribed strand, because
in Ung /Msh2  double knockout mice, C to T and G to A
mutations occur in roughly equal proportions (no strand bias
for AID deamination; reference 16). As such, Msh2 and
its cofactors are expected to remove either the U- or the
G-containing DNA strand, as observed in Escherichia coli for
a U:G mismatch in the absence of Ung (63). Removing the
U-containing strand, followed by DNA synthesis to replace
it, could result in mutations made by an error-prone pol,
such as pol   or pol  . Removing the G-containing strand
would result in a similar scenario, except that in addition,
the nonexcised strand contains a uracil base (Fig. 5). Inter-
estingly, in vitro, human Ung is able to excise U from sin-
gle-stranded DNA 2.5-fold (and a predicted 40-fold in vivo)
better than from double-stranded DNA (17, 64). Thus, the
single-stranded region produced by mismatch repair might
provide a preferred substrate for Ung. A corollary of this hy-
pothesis is that the ability of Ung to excise AID-deaminated
cytosines is hampered by loss of Msh2. Ung inhibition re-
sults in an increase in C and G transitions, precisely what is
seen in both Ung- and Msh2-deficient cells, and to a higher
degree in the former as expected if Ung plays the major role
in removing uracils. In Ung  mice, 94–98% of the muta-
tions from C or G are transitions (15 and this paper),
whereas in Msh2  mice, only 84–88% of mutations from C
or G are transitions (16, 62). Thus, in the scenario described,
all of the transition mutations from C and G observed in
both Msh2- and Ung-deficient situations would be due to
AID deamination events left unrepaired by Ung. Therefore,
we expect that the great majority of C and G transitions
mapped here in Ung  mice represent an accurate in vivo
AID footprint.
We found that the footprint of AID overlaps with the
distribution of SHMs in Ung  mice overall. Interestingly,
the overlap implies that during Msh2-mediated mismatch re-
pair at a U:G mismatch in Ig V regions during SHM, the
length of single-stranded DNA removed is only a few bp,
compared with the estimated length of as much as 1 kb dur-
ing mismatch repair outside of SHM (65). Removal of a
long tract of DNA by Msh2 and its cofactors during SHM,
initiated by an AID-generated mismatch, would have been
expected to expand the distribution of SHMs beyond the
AID footprint because error-prone pols could potentially
participate in resynthesis of the excised strand anywhere
along the length of the gap.
Thus, the interactions of various DNA repair systems and
AID appear rather complex. Finding that AID does not gain
access to the complete Ig gene elucidates one important aspect
of regulating AID, a potentially hazardous mutator factor.
MATERIALS AND METHODS
Mice, immunizations, and cell sorting. The Ung  mice on a hybrid
C57BL/6J-129SV background (37) were provided by D. Barnes and T.
Lindahl (Imperial Cancer Research Fund, Clare Hall Laboratories, UK) and
maintained in our facility by breeding with C57BL/6J or RS transgenic
mice, also on a C57BL/6J background. Ung  mice were genotyped by
PCR using two primer sets: UngF (5  GTGAATGCAGGGCTCACT-
TAAGTC 3 ) and UngR2 (5  CAGTGCCTATAACTTCAGCTCC) pro-
duce a 493-bp product in Ung  mice and a 1.6-kb product in Ung  mice;
NeoF (5  GTGAATGCAGGGCTCACTTAAGTC 3 ) and UngR2 pro-
duce an  600-bp product only in Ung  mice. PCR conditions were 1 cy-
cle at 96 C for 4 min, 96 C for 30 s, and 58–55 C for 30 s (touchdown an-
nealing), 7 cycles at 72 C for 1.5 min, followed by 30 identical cycles
except using a constant annealing temperature of 55 C, and a final exten-
sion cycle at 72 C for 7 min. The RS transgenic mice have been described
previously (39). The RS   transgene does not encode a functional protein
due to a stop codon in the leader exon and is therefore not selectable.
To immunize mice, 2   108 PBS-washed sheep red blood cells were
injected intraperitoneally on days 1 and 22. B cells were isolated on day 25
from the spleen and Peyer’s patches of immunized mice aged 4–10 mo.
Cells were stained with anti–mouse B220/CD45-PE (BD Biosciences),
anti–mouse PNA-FITC (Sigma-Aldrich), and anti–mouse GL7-FITC (BD
Biosciences) antibodies and sorted on a Mo-Flo or FACSAria (BD Bio-
sciences) cell sorter at the Immunology Core Facility at the University of
Chicago. PNAlowB220  and PNAhighB220  cells were collected for DNA
extraction using DNeasy columns (QIAGEN).
Figure 5. Model of codependence of Ung and mismatch repair 
activities in SHM.NO AID ACCESS TO THE 5  AND 3  ENDS OF IG GENES | Longerich et al. 1452
The Animal Care and Use Committee of the University of Chicago
has approved the animal studies.
PCR amplification and sequencing. To amplify a 991-bp segment of
the Ig  gene with a V 1-J 1 rearrangement, primers were designed to hy-
bridize at  453 bp upstream of the transcriptional start for the V 1 gene (5 
TCCCAGATTTAGACTCATTATACTACACAC) and  538 bp down-
stream in the J 1 region (5  CACGGACAGGATCCTAGGACAGTCAG-
TTTG). PCRs were performed with DNA template from 12,000 splenic
PNAhigh B cells using Pfu pol (Stratagene) for 25 cycles at 98 C for 45 s,
54 C for 45 s, and 72 C for 2 min.
VJ558-rearranged IgH genes were amplified as described previously
(33, 66) using  10,000–20,000 cell equivalents of template DNA from
splenic germinal center B cells, Pfu turbo pol (Stratagene), and PCR using 1
cycle at 95 C for 4 min, 95 C for 40 s, and 64–58 C for 40 s (touchdown
annealing), 13 cycles at 72 C for 4 min, followed by 27 cycles at 95 C for
40 s, 57 C for 40 s, 72 C for 4 min, and a final extension at 72 C for 7 min.
J1, J2, J3, and J4 rearrangements were resolved approximately by agarose gel
electrophoresis, bands were excised, and DNA was purified using a gel ex-
traction kit (Qiaquick; QIAGEN). The actual J rearrangement was ulti-
mately revealed by DNA sequencing. Clones derived from hybrid PCR
products identified by polymorphisms located throughout the region as an-
alyzed by sequencing (33) were excluded.
To amplify a 1,265-bp segment of the RS transgene between  301 to
 964 bp relative to the transcription start, the following primers were used:
the forward primer (5  GTTACTTTTGTCTCCTTGTCATTACAGG),
which anneals to 300 bp upstream of the transcription start in the RS trans-
gene, and the reverse primer (5  TGTAGCACCTGTCCATGGTTAGCA),
which anneals to the RS insert, a sequence that is unique to the RS transgene.
Two sets of primers were used to amplify the two downstream sections of
the RS transgene from PNAhigh Peyer’s patch B cells: JRH1F (5  GCAGAT-
GTAGATTCAGGTGCT) and 950R (5  GCCCTCTCCATTTTCTCAA-
GAT, unique to the RS transgene), which amplify a region between  141
and   1100 relative to the transcription start; and RsendF (5  CTACCA-
GAATTCAGTTCTCACGTTC, unique to the RS transgene) and
mIGkJCR (5  CTAATGGTTTGTAACCACATGGGAC), which amplify
the region between  950 and  2,982 nt relative to the transcription start.
PCR was performed using 1 cycle at 95 C for 4 min, 27 cycles at 95 C for 30 s,
55 C for 30 s, and 72 C for 3 min, followed by 1 cycle at 72 C for 7 min.
For all DNA, PCR products were gel purified using the Qiaquick gel ex-
traction kit and cloned using the Zero Blunt Topo PCR Cloning Kit (Invitro-
gen). Individual colonies were picked for automated DNA preparation and se-
quencing using M13F (5  GTAAAACGACGGCCAGT) and M13R (5 
CACACAGGAAACAGCTATGACCAT) primers at the University of Chi-
cago DNA Sequencing Core Facility. Additional sequencing primers used were
JCintronRseq (5  CAGTTCTGAATAGGGTATGAGAGAGCC), which
hybridizes to nt 2,120 to 2,146 (relative to GenBank/EMBL/DDBJ under ac-
cession no. X53774) between the end of J4 and the 3  primer used for PCR,
which is complementary to nt 2,429–2,458, located 3  of the IgH intron en-
hancer (66); mIgkJCseqF (5  GTGGGATAGCAGAGTTGAGTGAGC); and
mIgkJCR to sequence the furthest 3  portion of the RS transgene.
Mutation analyses. For all mutation analyses shown, all duplicate muta-
tions were included in the totals to purposefully overestimate mutations
found in the mutation-poor 5  and 3  regions of the genes examined. Nev-
ertheless, we found only a few duplicated clones, and the data therefore are
not significantly altered by retaining them (not depicted).
Statistical analyses. Simulations were performed using the R statistical
software (R Foundation: http://www.r-project.org). To test the null hy-
pothesis of a flat mutation rate, simulated datasets were created by generating
random positions along the sequence. P-values were calculated as twice the
percentage of simulations that had fewer mutations in the region investigated
than in the collected data (e.g., a p-value of 0.0004 indicates that 4 simulated
datasets out of 10,000 had a lower number of mutations in the region).
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